Therefore, we recommend that patients with COPD who also have diabetes, high BP, dyslipidemia, or reduced fasting glucose levels begin using insulin, lipid-lowering medications, and oral hypoglycemic medications. This evidence concerns the gene INS and metabolic syndrome.